Header cover image

Belgian (BEL20) Biotech Industry Analysis

UpdatedSep 15, 2025
DataAggregated Company Financials
Companies3
  • 7D-0.6%
  • 3M36.2%
  • 1Y32.7%
  • YTD5.4%

In the last week, Biotech has been flat. As for the the longer term, the industry is up 32% over the past 12 months. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Belgian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 15 Sep 2025€39.5b€2.7b€1.1b36.1x36.4x14.6x
Wed, 13 Aug 2025€33.8b€2.7b€1.1b33.3x31x12.4x
Fri, 11 Jul 2025€29.7b€2.3b€904.4m34.2x32.9x12.9x
Sun, 08 Jun 2025€31.6b€2.4b€928.6m35.1x34x13.3x
Tue, 06 May 2025€35.4b€2.0b€730.7m43x48.4x17.4x
Thu, 03 Apr 2025€32.8b€2.1b€759.0m42.6x43.2x15.5x
Sat, 01 Mar 2025€37.2b€2.2b€791.8m45.3x47x16.8x
Mon, 27 Jan 2025€38.0b€1.9b-€47,227,258.30n/a-804.3x20.4x
Wed, 25 Dec 2024€36.6b€1.9b-€47,593,924.60n/a-768.1x19.4x
Fri, 22 Nov 2024€34.2b€1.9b-€47,263,522.00n/a-722.6x18.3x
Sun, 20 Oct 2024€30.5b€1.6b-€196,923,572.50n/a-154.9x19.4x
Tue, 17 Sep 2024€29.1b€1.5b-€192,085,417.00n/a-151.3x19x
Thu, 15 Aug 2024€28.6b€1.5b-€194,661,391.00n/a-147x18.5x
Sat, 13 Jul 2024€25.7b€1.4b-€309,697,565.10n/a-82.9x18.7x
Mon, 10 Jun 2024€21.1b€1.4b-€312,614,798.20n/a-67.6x15.2x
Wed, 08 May 2024€21.8b€1.2b-€283,636,774.10n/a-76.9x17.9x
Fri, 05 Apr 2024€21.6b€1.2b-€281,541,897.80n/a-76.6x17.8x
Sun, 03 Mar 2024€21.3b€1.2b-€303,771,908.40n/a-70.2x17.6x
Tue, 30 Jan 2024€21.0b€1.0b-€289,043,441.00n/a-72.6x20x
Thu, 28 Dec 2023€20.6b€1.0b-€283,579,661.00n/a-72.5x20.1x
Sat, 25 Nov 2023€26.8b€1.0b-€286,986,431.00n/a-93.5x25.8x
Mon, 23 Oct 2023€26.7b€880.7m-€451,828,402.00n/a-59x30.3x
Wed, 20 Sep 2023€28.7b€870.8m-€452,877,992.00n/a-63.4x33x
Fri, 18 Aug 2023€26.9b€847.4m-€455,298,162.00n/a-59x31.7x
Sun, 16 Jul 2023€18.7b€647.2m-€544,146,437.00n/a-34.4x28.9x
Tue, 13 Jun 2023€20.8b€674.4m-€566,385,165.00n/a-36.6x30.8x
Thu, 11 May 2023€20.4b€635.8m-€547,291,511.00n/a-37.3x32.1x
Sat, 08 Apr 2023€19.7b€457.3m-€731,958,683.00n/a-26.9x43x
Mon, 06 Mar 2023€18.2b€316.1m-€917,776,202.00n/a-19.9x57.7x
Wed, 01 Feb 2023€19.4b€310.0m-€899,470,461.00n/a-21.6x62.7x
Fri, 30 Dec 2022€19.7b€315.0m-€909,969,875.00n/a-21.6x62.5x
Sun, 27 Nov 2022€20.5b€322.8m-€933,182,311.00n/a-22x63.6x
Tue, 25 Oct 2022€21.3b€193.2m-€985,349,030.00n/a-21.6x110x
Thu, 22 Sep 2022€20.8b€173.0m-€978,936,040.00n/a-21.2x120x
Price to Earnings Ratio

-21.2x


Total Market Cap: €20.8bTotal Earnings: -€978,936,040.00Total Revenue: €173.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Biotech Industry Price to Earnings3Y Average -124.7x202320242025
Current Industry PE
    There are only 3 companies in the Belgian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 151% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Belgian Healthcare industry?

BE Market-0.30%
Healthcare-1.01%
Biotech-0.62%
Biotech-0.62%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OXUR Oxurion€0.0230.9%
+€10.1k
-96.3%PE9.7x

Latest News